Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01566747 |
|
Recruitment Status :
Completed
First Posted : March 29, 2012
Last Update Posted : December 23, 2021
|
Sponsor:
Cancer Trials Ireland
Collaborator:
Novartis
Information provided by (Responsible Party):
Cancer Trials Ireland
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 7, 2020 |
| Actual Study Completion Date : | July 15, 2020 |